MAPT and Alzheimer disease: In the present study, we analyzed various tau fractions isolated from AD cerebral cortex at NFT stages V-VI and found that various AD tau fractions displayed different biochemical and prion-like properties, indicating the heterogenicity of pathological activity of tau fractions in AD brains.